Equity and long-term bank financing · Biotech

MicroCyto secures ¥1.5 billion in equity and loans for Yuxin acquisition

The financing combines investment from three backers with long-term lending from Industrial Bank’s Beijing branch.

MicroCyto announced ¥1.5 billion in new financing on May 13, 2026, combining equity and long-term bank loans. Zhang Qibin, Tan Ruiqing and Xingyin Investment participated in the equity component, while Industrial Bank Beijing Branch provided the loans. The split between debt and equity was not disclosed.

The package will fund the acquisition of Yuxin, a sugar-alcohol producer, and the large-scale production of bulk ingredients. Yuxin brings established factories and distribution channels to MicroCyto’s microbial-engineering and fermentation technologies.

MicroCyto aims to use biological production to manufacture products such as xylitol. The acquisition connects its process development with existing industrial capacity and customers in food, pharmaceuticals and personal care.

Use of funds

Acquire Yuxin sugar-alcohol manufacturing business and scale production of bulk bio-based ingredients.

Funding history

Equity and long-term bank financing · This roundCN¥1.5B
Series A+CN¥300MEquity financing~CN¥300M

Sources

  1. MicroCyto raises CNY1.5bn in equity and long-term bank financingvbdata.cn · May 13, 2026